Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS are more likely to have fatty liver disease.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

The document suggests a new model for evaluating public research that better captures the full value of knowledge creation and use, using PCOS research as an example.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.